Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was CNY 6,580.278 million compared to CNY 6,002.471 million a year ago. Operating loss was CNY 1,195.362 million compared to operating Income of CNY 422.415 million a year ago. Net loss was CNY 1,296.605 million compared to net income of CNY 319.383 million a year ago. Basic loss per share from continuing operations was CNY 0.8 compared to basic earnings per share from continuing operations of CNY 0.19 a year ago.